Talking It Out: Perseverance Helps Sponsors Overcome Disagreements With FDA

Some of the most valuable lessons learned out of Pharmaceutical Approvals Monthly’s Drug Review Profile series involve getting FDA to be flexible about what kind of clinical data it requires.